At Investor Conferences

 
 

Business Parks & Science Centres

 
 
 

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > All

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 2448 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Berlin Partner. (April 2019). "Special Feature: BIONNALE 2019 in Berlin – the Networking Event for the Life Sciences & Healthcare Industries in the German Capital Region". Berlin. 2019-04-21
[iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. 2019-04-20
HalioDx S.A.S.. (4/19/19). "Press Release: HalioDx Signs an Exclusive Agreement with Genecast to Make Immunoscore Available in China". Marseille. 2019-04-19
Cerenis Therapeutics S.A.. (4/17/19). "Press Release: Cerenis Therapeutics Has Decided to Terminate the Proposed Merger with H4Orphan Pharma". Toulouse. 2019-04-17
MLM Medical Labs GmbH. (4/15/19). "Press Release: Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project to Enable Development and Implementation of Novel Safety Biomarkers". Mönchengladbach. 2019-04-15
Theranexus S.A.. (4/9/19). "Press Release: Theranexus Announces Research Collaboration with IRISA Using Artificial Intelligence Technologies to Enhance Therapeutic Targeting of Neurological Interactions". Lyon. 2019-04-09
Nanobiotix S.A.. (4/4/19). "Press Release: Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval". Paris & Cambridge, MA. 2019-04-04
AgomAb Therapeutics N.V.. (4/3/19). "Press Release: AgomAb Therapeutics Completes Euros 21m Series A Financing". Ghent. 2019-04-03
Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data". Brisbane, CA. 2019-04-02
Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Announces Agreement Securing Access To Large-scale, Commercial-grade Manufacturing Capacity at Brammer Bio". Brisbane, CA. 2019-04-02
Nanobiotix S.A.. (4/2/19). "Press Release: Combination of First-in-Class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in Vivo Models of Lung Cancer". Paris & Cambridge, MA. 2019-04-02
Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy". Brisbane, CA & New York, NY. 2019-04-02
Karuna Therapeutics, Inc.. (4/1/19). "Press Release: Karuna Completes $80 Million Series B Financing". Boston, MA. 2019-04-01
Evotec SE. (4/1/19). "Press Release: Evotec AG Completes Conversion into Evotec SE". Hamburg. 2019-04-01
Surface Oncology Inc.. (4/1/19). "Press Release: Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer". Cambridge, MA. 2019-04-01
Celyad S.A.. (3/28/19). "Press Release: Celyad Appoints Filippo Petti as Chief Executive Officer. Dr Christian Homsy Continues as Non-executive Director and Chair of the Strategy Committee of the Board of Directors". Mont-Saint-Guibert. 2019-03-28
Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel. 2019-03-28
Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris. 2019-03-28
Evotec AG. (3/28/19). "Press Release: Evotec AG Fiscal Year 2018 Results – Accelerated Growth and Strong Long-term Outlook". Hamburg. 2019-03-28
Cerenis Therapeutics S.A.. (3/27/19). "Press Release: Cerenis Therapeutics and H4Orphan Pharma Enter into Exclusive Negotiations to Consider a Strategic Merger". Toulouse. 2019-03-27
Genfit S.A.. (3/27/19). "Press Release: Genfit Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market". Lille & Cambridge, MA. 2019-03-27
Pierre Fabre S.A.. (3/21/19). "Press Release: Institut Curie and Pierre Fabre Strengthen Their Immuno-oncology Partnership". Paris & Castres. 2019-03-21
Vivet Therapeutics S.A.S.. (3/20/19). "Press Release: Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics". Paris & New York, NY. 2019-03-20
Merck KGaA. (3/14/19). "Press Release: Merck Announces Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology [Not intended for US, Canada and UK-based media]". Darmstadt. 2019-03-14
Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. 2019-03-14
Oxford BioMedica plc. (3/14/19). "Press Release: Oxford Biomedica plc Preliminary Results for the Year Ended 31 December 2018". Oxford. 2019-03-14
Genfit S.A.. (3/14/19). "Press Release: Genfit Announces Launch of Proposed Global Offering and Nasdaq Listing". Lille & Cambridge, MA. 2019-03-14
Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. 2019-03-11
Celyad S.A.. (3/8/19). "Press Release: Celyad Appoints Anne Moore as Vice President Corporate Strategy". Mont-Saint-Guibert. 2019-03-08
Sartorius AG. (3/5/19). "Press Release: Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography". Göttingen. 2019-03-05
Seventure Partners. (3/5/19). "Press Release: Health for Life Capital II, World Leading Microbiome-focused Fund Announces its First Close". Paris. 2019-03-05
Eurofins Scientific. (3/5/19). "Press Release: Eurofins Delivers Solid FY 2018 Results with Revenues of EUR 3,781m (+27% yoy) and Adjusted EBITDA of EUR 720m (19.0% of revenues), in Line with Its Recently Upgraded Objectives". 2019-03-05
Seventure Partners. (3/1/19). "Press Release: Seventure Partners Life Sciences Corporate Update September 2018 – February 2019". Paris. 2019-03-01
Genfit S.A.. (2/27/19). "Press Release: Genfit Files Registration Statement for Proposed Initial Public Offering in the United States". Lille & Cambridge, MA. 2019-02-27
Ynsect S.A.. (2/21/19). "Press Release: Ÿnsect Raises $125m to Become World Leader in Alternative Protein". Paris & London. 2019-02-21
PX’Therapeutics S.A.. (2/20/19). "Press Release: 2019 – PX’Therapeutics Develops Its Services Offer". 2019-02-20
Seventure Partners. (2/20/19). "Press Release: Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C". Paris. 2019-02-20
BiomX Ltd.. (2/20/19). "Press Release: BiomX Raises $32 Million in Series B Financing. Proceeds Will Be Used Primarily to Advance Leading IBD and Acne Programs to the Clinic". Ness Ziona. 2019-02-20
France Biotech. (2/19/19). "Press Release: France Biotech Announces Launch of HealthTech Investor Day in Paris on June 25th, 2019". Paris. 2019-02-19
Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. 2019-02-14
Charles River Laboratories International, Inc.. (2/13/19). "Press Release: Charles River Laboratories Signs Binding Offer to Acquire CiToxLab". Wilmington, MA. 2019-02-13
Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. 2019-02-12
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. 2019-02-11
Eurofins. (2/11/19). "Press Release: New Site for Microbiology and DNA Analysis in Bremerhaven. Q-Bioanalytic Strengthens the Eurofins Laboratory Network". 2019-02-11
Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". 2019-02-08
bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. 2019-02-07
Oxford BioMedica plc. (2/7/19). "Press Release: Oxford Biomedica Provides Update on Programmes Outlicensed to Sanofi". Oxford. 2019-02-07
Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. 2019-02-07
OSE Immunotherapeutics S.A.. (2/7/19). "Press Release: OSE Immunotherapeutics and Servier Announce First Option within Global License Agreement Exercised for further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases". 2019-02-07
Sanofi S.A.. (2/6/19). "Press Release: Sanofi’s Board of Directors Notes the Resignation of Christian Mulliez and Co-opts Christophe Babule as Director". Paris. 2019-02-06
Rewind Therapeutics. (2/6/19). "Press Release: Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing further Expertise in Myelin and Multiple Sclerosis Research". Leuven. 2019-02-06
Sanofi S.A.. (2/6/19). "Press Release: FDA Approves Cablivi (caplacizumab-yhdp), the First Nanobody-based Medicine, for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2019-02-06
Sanofi S.A.. (2/5/19). "Press Release: Isatuximab Phase 3 Trial Meets Primary Endpoint of Prolonging Progression Free Survival in Patients with Relapsed/Refractory Multiple Myeloma". Paris. 2019-02-05
Sanofi S.A.. (2/4/19). "Press Release: CHMP Recommends Approval of Praluent (alirocumab) to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease". Paris & Tarrytown, NY. 2019-02-04
[iito] Business Intelligence. (2/1/19). "Press Release: [iito] Web Portals Surpass Half a Million Page Views per Month". Bremen. 2019-02-01
Symrise AG. (1/31/19). "Press Release: Symrise Strengthens Pet Food Activities and Expands US Footprint with Acquisition of ADF/IDF". 2019-01-31
Sanofi S.A.. (1/30/19). "Press Release: Fexinidazole, the First All-oral Treatment for Sleeping Sickness, Approved in Democratic Republic of Congo". Paris & Geneva. 2019-01-30
Allogene Therapeutics, Inc.. (1/28/19). "Press Release: Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy". South San Francisco, CA & Paris. 2019-01-28
Cerenis Therapeutics S.A.. (1/24/19). "Press Release: 2018 Annual Results and Clinical Update". Toulouse & Lakeland, US. 2019-01-24
Sartorius AG. (1/23/19). "Press Release: Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)". Göttingen & Glasgow. 2019-01-23
Pharnext S.A.. (1/23/19). "Press Release: Pharnext Raises €15 Million without Discount". Paris. 2019-01-23
Innovative Medicines Initiative (IMI). (1/22/19). "Press Release: Open Access Drug Development Tools Feature in New IMI Call for Proposals". Brussels. 2019-01-22
Voyager Therapeutics, Inc.. (1/22/19). "Press Release: Voyager Therapeutics Appoints Robert Hesslein as General Counsel". Cambridge, MA. 2019-01-22
Kurma Partners. (1/21/19). "Press Release: Kurma Partners Sees Great Opportunities for Early-stage Biotech Investments in Germany and Launches Operations in Munich". Paris & Munich. 2019-01-21
ImaBiotech S.A.S.. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille. 2019-01-17
Carbios S.A.. (1/17/19). "Press Release: Carbios and TWB Receive €7.5 Million Funding to Accelerate the Industrialization of the Biorecycling of PET Plastics and Fibers". Clermont-Ferrand. 2019-01-17
Sanofi S.A.. (1/17/19). "Press Release: FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes". Paris & The Woodlands, TX. 2019-01-17
ImaBiotech S.A.S.. (1/17/19). "Press Release: Metabrain Research and ImaBiotech Initiate a Strategic Partnership to Offer Cuttingedge Preclinical Research Services in Metabolic Disorders". Lille. 2019-01-17
Nanobiotix S.A.. (1/16/19). "Press Release: Nanobiotix Plans to Conduct Registered Public Offering in the United States". Paris & Cambridge, MA. 2019-01-16
Biomunex Pharmaceuticals SASU. (1/15/19). "Press Release: Biomunex Pharmaceuticals Signs a Licensing Agreement with Sanofi for the Development of Bi- and Multi-specific Antibodies". Paris. 2019-01-15
[iito] Business Intelligence. (1/11/19). "Press Release: [iito] Discontinues Life-Sciences-UK.com and Life-Sciences-France.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2019-01-11
Valneva S.E.. (1/7/19). "Press Release: Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate". Saint-Herblain. 2019-01-07
Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. 2019-01-07
Sanofi S.A.. (1/7/19). "Press Release: Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs". Paris & Tarrytown, NY. 2019-01-07
BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz. 2019-01-04
Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA. 2019-01-04
Vedanta Biosciences. (12/24/18). "Press Release: Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates". Cambridge, MA. 2018-12-24
Valneva S.E.. (12/21/18). "Press Release: Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate". Saint-Herblain. 2018-12-21
Novartis AG. (12/21/18). "Press Release: Novartis Successfully Completes Acquisition of Endocyte". Basel. 2018-12-21
Novartis AG. (12/20/18). "Press Release: Novartis Announces New CEO of Oncology Business Unit". Basel. 2018-12-20
Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. 2018-12-20
Protagen AG. (12/18/18). "Press Release: Protagen AG Appoints Immuno-Oncology Experts to Its Scientific Advisory Board". 2018-12-18
Sanofi S.A.. (12/18/18). "Press Release: Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq". Paris. 2018-12-18
Carmat S.A.. (12/17/18). "Press Release: The European Investment Bank Supports Carmat with €30 Million for the Marketing Process of Its Total Artificial Heart". Paris. 2018-12-17
Valneva S.E.. (12/17/18). "Press Release: Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate". Saint-Herblain. 2018-12-17
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. 2018-12-14
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. 2018-12-13
Curetis N.V.. (12/13/18). "Press Release: Curetis Sharpens Focus on Near-term Strategic Value Drivers. Business Focus on U.S. Commercialization, Strategic Partnering, Ares Genetics and Asset Monetization". Amsterdam, Holzgerlingen & San Diego, CA. 2018-12-13
Polyplus-transfection S.A.. (12/13/18). "Press Release: Polyplus-transfection further Expands Transfection Reagent Portfolio for Cell and Gene Therapy GMP production". Strasbourg. 2018-12-13
Carmat S.A.. (12/12/18). "Press Release: Carmat Announces the Appointment of Pascale d’Arbonneau as Chief Financial Officer". Paris. 2018-12-12
MyNewGut Project. (12/10/18). "Press Release: Gut Microbiota Linked to Obesity and Mental Disorders, EU-funded Project »MyNewGut« Finds". 2018-12-10
Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt. 2018-12-10
Valneva S.E.. (12/6/18). "Press Release: Valneva and Hookipa Sign a Collaboration and Manufacturing Agreement". Saint-Herblain & Vienna. 2018-12-06
Abivax S.A.. (12/6/18). "Press Release: Abivax Receives DSMB Recommendation to Continue Ongoing Extension Study of Its Completed Phase 2a Clinical Trial in Ulcerative Colitis patients". Paris. 2018-12-06
L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. 2018-12-05
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour 2018-12-04
Allogene Therapeutics, Inc.. (12/3/18). "Press Release: Allogene Therapeutics Presents Data from Preclinical Study of ALLO-715 (anti-BCMA) Demonstrating Allogeneic CAR T Potential in Multiple Myeloma at the 2018 ASH Annual Meeting". South San Francisco, 2018-12-03
Allogene Therapeutics, Inc.. (12/3/18). "Press Release: Allogene Therapeutics and Servier Present Pooled Data from Phase 1 Trials of Allogeneic UCART19 in Relapsed/Refractory Acute Lymphoblastic Leukemia". South San Francisco, CA & Paris. 2018-12-03
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

» top